Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday, 16 October 2017

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Stephen Opat et al. published in the New England Journal of Medicine.

Read article here.

No comments:

Post a Comment